RecruitingPhase 2NCT07398287

Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Region Skane
Principal Investigator
Zainab Ahmadi
Region Skåne and Lund University
Intervention
L-menthol(drug)
Enrollment
20 target
Eligibility
18 years · All sexes
Timeline
20262027

Study locations (2)

Collaborators

Blekinge Institute of Technology · Blekingesjukhuset, Karlskrona · Lund University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07398287 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease

← Back to all trials